Serum Sickness Following Equine Rabies Immunoglobulin Administration - A Case Study

  • Swetaleena Ashe Junior Resident, Department of Community Medicine, SCB Medical College and Hospital, Cuttack, Odisha, India.
  • Dipanweeta Routray Assistant Professor, Department of Community Medicine, SCB Medical College and Hospital, Cuttack, Odisha, India.
  • Tapas Ranjan Behera Assistant Professor, Department of Community Medicine, SCB Medical College and Hospital, Cuttack, Odisha, India.
Keywords: Serum Sickness, Equine Rabies Immunoglobulin, Adverse Drug Reaction Monitoring, Rabies, Anti-Rabies Vaccination

Abstract

A fourteen years old male child presented to the Anti-Rabies Clinic of a tertiary care hospital with rashes all over the body associated with myalgia and mild fever following treatment with Anti-Rabies vaccine and Equine Rabies Immunoglobulin (ERIG) for Category III monkey bite injury. On tenth day of vaccination, the child developed generalized rashes all over the body. He was primarily treated with anti-histaminics and analgesics. However, the rashes still increased in size and later involved the whole body including the face. He was then treated with corticosteroids (Injection Dexamethasone 4 mg/ 2 mL) and was completely cured after three days. The adverse reaction following ERIG administration was diagnosed as a case of Serum Sickness and reported to the Adverse Drug Reaction Monitoring Centre of the College. The purpose of this case study is to create awareness about the adverse drug reactions following ERIG administration among the health care personnel, importance of prompt management of such Serum Sickness cases and timely reporting to the ADR Monitoring Centre. It has its own implications for policy makers.

References

National Guidelines for Rabies Prophylaxis and Intradermal Administration of Cell Culture Rabies

Vaccines. National Institute of Communicable Diseases. 2007.

Tripathy RM, Satpathy SP, Das S. Outcome of skin sensitivity test for assessing adverse reactions to equine

rabies immunoglobulin in a tertiary setup of South Odisha. APCRI Journal 2018; 19(2): 13-15.

Yerushalmi J, Zvulunov A, Halevy S. Serum Sickness-like reactions. Cutis 2002; 69(5): 395-397.

Serum sickness. Available from: http://en.m.wikipedia.org/wiki/Serum_sickness.

Satapathy DM, Sahu T, Behera TR et al. Socio clinical profile of rabies cases in anti-rabies clinic, MKCG

Medical College Orissa. Indian Journal of Public Health 2005; 49(4): 241-242.

Mohanty S, Behera TR, Pattnaik N. Clinical safety of an equine rabies immunoglobulin, APCRI Journal 2018;

(2): 9-11.

Mohammad K, Gupta P. A study of human rabies cases admitted in infectious disease hospital KGMU, Lucknow, North India. Int J Community Med Public Health 2018; 5(11): 4795-4798.

Ashwath Narayana DH, Ravish HS, Ramesh Holla. Clinical evaluation of safety of Equine Rabies immunoglobulin. APCRI Journal 2011; 12(2): 12-15.

Sudarshan MK. Assessing burden of rabies in India: WHO sponsored National multicentric Rabies survey,

Indian Journal of Community Medicine 2005; 30(3): 100-101.

Shwetha, Vinay M, Harish Br. Effectiveness of child to child method of Education regarding Rabies and its

prevention. APCRI Journal 2018; 19(2): 28-29.

Behera TR, Satapathy DM, Pratap AK et al. Postexposure prophylaxis for rabies with ERIG and IDRV

in children. J Commun Dis 2011; 43(1): 31-37.

Wilde H, Chomchey P, Punyaratabandhu P. Purified equine rabies immune globulin: A safe and affordable

alternative to human rabies immunoglobulin. Bulletin of the WHO 1989; 67(6): 731-736.

Maharana S, Behera TR, Pattnaik N. Serum sickness in patients receiving equine rabies immunoglobulin.

J Commun Dis. 2018; 50(2): 1-4.

Published
2019-12-23